Clinical Trial Update: Moxonidine in Patients Undergoing Vascular Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating moxonidine in patients undergoing vascular surgery was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Vascular Disease

Drugs mentioned

• Moxonidine (moxonidine)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Cardiac Disease, Vascular Surgery | Phase 3 | Status: TERMINATED